InsidersTradesSigma
Browse the complete record of transactions filed by Tian Wenzhi, Dirigeant. Insider active across 1 companies, notably ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B. Cumulatively, 1 disclosures have been published. The latest transaction was disclosed on 13 May 2026 — Purchase. Regulator: HKEX. The full history is openly available.
1 of 1 declaration
Tian Wenzhi is an executive at ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares. He is responsible for managing operations and developing new treatments in the biopharmaceutical field. Tian contributes to innovation and advancement of therapeutic solutions aimed at improving patient health.